Search
Roche Subsidiary Genentech Aims to Invest Over $700 Million in U.S. Pharmaceutical Plant Construction
2025-05-13 /
Read about 0 minute
Author：小编
Genentech, a subsidiary of Roche, intends to invest more than $700 million in the construction of a new pharmaceutical plant in Holly Springs, North Carolina, in the United States. This facility will primarily focus on manufacturing Roche and Genentech's next-generation portfolio of obesity medications, with the flexibility to further increase investments based on evolving business requirements and the regulatory landscape in the United States.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
